RESEARCH USE ONLY: All products are for laboratory research purposes only. Not for human or animal consumption.
By using this site, you confirm you are 21+ and acknowledge these products are not FDA approved.
← Back to Research Library
Mechanism of Action
CJC-1295 with DAC is a synthetic GHRH(1-29) analogue modified with a maleimidopropionic acid linker enabling covalent albumin binding. This extends half-life from minutes to 6-8 days for sustained GH/IGF-1 elevation without frequent dosing.
Key Research Findings
- Single injection elevated mean GH levels for 6+ days and IGF-1 for 9-11 days
- 2-10 fold increase in mean GH concentration at steady state with weekly dosing
- Preserved natural pulsatile GH release pattern
Peer-Reviewed Studies (1)
Teichman SL, Neale A, et al.
Journal of Clinical Endocrinology and Metabolism (2006)
CJC-1295 DAC produced dose-dependent GH and IGF-1 elevation lasting 6-14 days after single injection
Research Disclaimer: The studies referenced above are from publicly available peer-reviewed literature. Pepta Labs products are sold strictly for research purposes. They are not intended for human consumption, therapeutic use, or as dietary supplements. All information is provided for educational and research reference only.